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Letters to the Editor
The Prevalence of Chlorpropamide Alcohol Flushing in Non-Insulin Dependent Diabetics
Dear Sir, Leslie and Pyke have suggested that the chlorproparnide alcohol flush is a dominantly inherited trait in non-insulin dependent diabetics which is associated with a low prevalence of severe retinopathy [1, 2] , K6bberling and his colleagues have recently been unable to confirm these observations [3] . They found that the chlorpropamide alcohol flush was not specific for non-insulin dependent diabetics and they were unable to find any differences in the distribution of the chlorpropamide alcohol flush in diabetics with or without a family history of the disease.
We have performed the chlorpropamide alcohol flush test in 108 patients using 40 ml of sherry 12 h after 250 mg of chlorpropamide. The presence of a chlorpropamide alcohol flush was judged using facial temperature measurement, the feeling of a facial warmth by the patient or the appearance of a facial flush. The presence or absence of retinopathy was made following an examination through dilated pupils by an ophthalmologist who was unaware of the chlorpropamide alcohol flush status. A chlorpropamide alcohol flush occurred in 35 (33%) of noninsulin dependent diabetics (Table 1) . A positive test was obtained in 43% of the patients exhibiting a chlorpropamide alcohol flush when sherry was given alone without the previous administration of chlorpropamide. There was no difference in the prevalence of a family history of diabetes or background retinopathy in the two groups. There was however a greater percentage of patients with more than five exudates and/or haemorrhage in the chlorpropamide alcohol flush-positive patients (Table 1 ). Interestingly, there was an increased number of females in the chlorpropamide alcohol flush-positive group (p < 0.025).
In our experiment the chlorpropamide alcohol flush test, therefore, is not very specific since a sizeable proportion of chlorpropamide alcohol flush-positive patients showed a positive response to alcohol alone. The prevalence of chlorpropamide alcohol flushpositive tests was not increased in patients with a family history of diabetes nor did we find evidence that cblorpropamide alcohol flush-positive patients are protected against severe retinopathy.
Our conclusions therefore agree with Kbbberling et al. [3] in that the chlorpropamide alcohol flush test is unsuitable for genetic counselling and should not be used for the prognostic labelling of non-insulin dependent diabetic patients. 
Delayed Menarche as an Indicator of a
Dear Sir, Bailey and Ahmed-Sorour [1] have recently demonstrated that normal ovarian endocrine function plays an important role in the long-term maintenance of glucose homeostasis. There are also reports that oestrogen increases the sensitivity of adipose tissue and skeletal muscle to the action of insulin [2] . This may explain why ovariectomy increases the incidence and severity of experimental diabetes in female animals [3] .
These observations also may be relevant to certain clinical findings concerning ovarian function in diabetic women. We have found that the age of onset of menarche in 986 women in whom Prediabetic State diabetes appeared after the age of 20 years occurred significantly later (p < 0.01) than in I952 non-diabetic subjects (14.2 + 1.9 versus 12.8 • 1.2 years) [4] . The number of diabetic women who had menarche at or after the age of 15 years (29%) was higher than that found in non-diabetic women (6%) ( Table 1 ). The reason for this is difficult to define and requires further investigation, Disturbances in prolactin secretion [5] [6] [7] or the secretion of ovarian hormones [1] could provide an explanation.
Our data suggest that when menarehe is delayed after the age of 15 years, there may be a predisposition for diabetes. Such patients need periodic investigation. 
Cord Blood C-Peptide: Glucose Ratio -a Good Indicator of B Cell Function in Infants of Diabetic Mothers
Dear Sir, We would like to supplement recent observations [1] on the B cell function in infants of diabetic mothers. We too, have measured cord blood C-peptide and glucose, the former after initial precipitation of insulin antibodies with polyethylene glycol [2] , to compare the true B cell response of a group of 44 infants of insulinrequiring diabetic mothers with 32 infants of non-diabetic mothers. We divided the infants of diabetic mothers into two groups dependent upon the quality of their mothers' blood glucose control and their glycosylated haemoglobin concentration [3] and not on the basis of the presence or absence of insulin antibodies. The results are presented below as group means + one standard deviation.
We found the mean cord blood glucose of our normal babies (3.9 • 1.0 mmol/1) was lower than that of infants of diabetic mothers (4.7 _+ 3.6 rnmol/l). The C-peptide values were: normal infants 0.18 + 0.1nmol/1 and infants of diabetics 0.46 • 0.44nmol/l. Comparison of the results using a variance ratio test showed that the cord blood glucose and C-peptide concentrations were significantly different. When the diabetic group was re-examined after subdivision on the basis of diabetic control the mean cord blood Cpeptide of infants of well controlled diabetic mothers was 0.28 + 0.3 nmol/1 compared with a mean of 0.56 • 0.5 nmol/1 for infants of poorly controlled mothers, a difference which is highly significant by the variance ratio test.
We have always believed that the cord blood C-peptide: glucose ratio at delivery avoids the problems of comparing B cell function of groups with different glucose values. We found the mean of the C-peptide:glucose ratio for infants of normal mothers was 0.049 • 0.029 whilst infants of diabetic mothers as a group had a higher mean at 0.110 +_ 0.09. When the ratios of infants of well and poorly controlled diabetic mothers were compared, infants of well controlled mothers had a significantly lower mean value of 0.06 • 0.06 compared with these of poorly controlled mothers 0.13 • 0.09 (p < 0.005). The value of this ratio is that it identifies those infants with inappropriate B cell response more clearly. Seventeen of our infants of diabetic mothers had a cord blood C-peptide above the observed upper limit of the range for normal infants (0.4 nmol/1) but two were shown to have a normal C-peptide: glucose ratio indicating a normal insulin responsiveness per unit of glucose; both mothers of these two infants had transient hyperglycaemia at delivery but otherwise had good diabetic control throughout the final trimester. However, the ratio was high in the other 15 infants and was consistent with poor maternal control during pregnancy.
The C-peptide:glucose ratio in cord blood therefore provides a better measure of B cell secretory status of the newborn of diabetics than C-peptide alone and provides a useful tool for retrospective evaluation of the diabetic control of the mothers. 
